Everyone deserves the best chance to survive
When it comes to cancer, newspapers tend to home in on tragic stories of young mothers or children. The big story of the explosion of cancer cases among the elderly and the urgent need for [more]
Senza categoria
Newsround
Selected reports edited by Janet Fricker Download full article
When is it OK to randomise cancer patients to placebo?
No-one wants to see progress in cancer research more than the patients themselves. But how do we deal with potential conflicts of interest when testing new drugs involves giving placebos to people dying of cancer? [more]
A reverence for life in turbulent times
A young child in war time Germany, Stephan Tanneberger grew up to take a lead in oncology in the communist East, which achieved some of the lowest cancer mortality rates in Europe. His career was [more]
If nothing is done…
The more we know about cancer, the harder it becomes to present a coherent and accurate picture of the nature of the threat and what canand what cannot be achieved through changing lifestyles, screening and [more]
N E W S R O U N D
Selected reports edited by Janet Fricker Download full article
Stopping trials prematurely: sorting the right decisions from the wrong
Allegations that commercial pressures may be leading to cancer drug trials being halted prematurely hit the news on both sides of the Atlantic last April. Industry leaders are pleading not guilty’. But how can we [more]
Balancing cure and care
Cornelis van de Velde went into cancer because he loved the complexity. Throughout his career he has grasped each new development across the disciplines to see how it could help resolve the difficult balance between [more]
The neglected magic bullet
Surgery still offers by far the best hope of a cure in solid tumours. Yet patients are being let down by too great a focus on drugs at the expense of investment in surgical equipment [more]
Personalised medicine: the dream and the reality
Recent years have seen a scramble to identify the genetic variance that predisposes or protects against certain cancers and the tumour gene signatures that could indicate which therapies will work and which won’t. A picture [more]
A scientist without borders
A biostatistician with medical training, Hélène Sancho-Garnier helped drive the shift towards evidence-based clinical practice in the ’60s and ’70s. Stepping nimbly over traditional boundaries, she went on to apply this approach to cancer registries, [more]
N E W S R O U N D
Selected reports edited by Janet Fricker Download full article
There’s a shadow in your head
Eric Baumann, a healthy 34-year-old, in love with life and his new girlfriend, had just started as the new London correspondent for the Swiss daily Tages-Anzeiger when he was diagnosed with brain cancer. His description, [more]